HS-1793, a recently developed resveratrol analogue protects rat heart against hypoxia/reoxygenation injury via attenuating mitochondrial damage

Bioorg Med Chem Lett. 2013 Jul 15;23(14):4225-9. doi: 10.1016/j.bmcl.2013.05.010. Epub 2013 May 15.

Abstract

Resveratrol is known to exert a cardioprotective effect against hypoxia/reoxygenation (H/R) injury. HS-1793 is a novel, more stable resveratrol analog, but its cardioprotective effects were unknown. The present study aimed to test the cardioprotective effect of HS-1793 against H/R injury and investigate the role of mitochondria in Sprague Dawley rat heart damage using an ex vivo Langendorff system. HS-1793 ameliorated H/R-induced mitochondrial dysfunction by reducing mitochondrial reactive oxygen species production, improving mitochondrial oxygen consumption and suppressing mitochondrial calcium (Ca(2+)) overload during reperfusion. Moreover, HS-1793-treated rat heart showed reduced infarct size. Our data suggest that HS-1793 can protect cardiac against mitochondrial damage following H/R, thereby suppressing injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism
  • Heart / physiopathology
  • Hypoxia
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Myocardial Reperfusion Injury / drug therapy
  • Myocardial Reperfusion Injury / metabolism
  • Myocardial Reperfusion Injury / pathology
  • Naphthols / chemistry*
  • Naphthols / pharmacology
  • Naphthols / therapeutic use
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species / metabolism
  • Resorcinols / chemistry*
  • Resorcinols / pharmacology
  • Resorcinols / therapeutic use
  • Resveratrol
  • Stilbenes / chemistry*

Substances

  • 4-(6-hydroxy-2-naphthyl)-1,3-benzenediol
  • Naphthols
  • Reactive Oxygen Species
  • Resorcinols
  • Stilbenes
  • Resveratrol
  • Calcium